Joseph Cama
Family Medicine · Towanda, PANPI 1841395928
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $684 and has fallen 92.1% since, to $54 in 2025.
Across 126 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$270
- AbbVie$234
- GSK$201
- Alkermes, Inc.$190
- Lilly USA, LLC$171
- Boehringer Ingelheim$121
- plus $712 from 19 others
What the payments were for
- Food & beverage$1,900100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $270 |
| AbbVie(2 entities) | 17 | $234 |
| GSK | 13 | $201 |
| Alkermes, Inc. | 9 | $190 |
| Lilly USA, LLC | 15 | $171 |
| Boehringer Ingelheim | 9 | $121 |
| Indivior Inc. | 7 | $106 |
| Astellas Pharma US Inc | 6 | $99 |
| Amarin Pharma, Inc. | 5 | $78 |
| Johnson & Johnson | 5 | $71 |
| Novo Nordisk | 5 | $61 |
| Novartis | 3 | $46 |
| Dexcom, Inc. | 3 | $38 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Titan Pharmaceuticals, Inc. | 2 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Biogen | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Amgen | 1 | $12 |
How this compares
$1,900 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 11 | $203 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Towanda
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.